Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival

Clinical Cancer Research

Volumn 9, Issue 2, 2003, Pages 613-618

  Kinch, Michael S ^a   Moore, Mary Beth ^b   Harpole Jr , David H ^b  

^a MEDIMMUNE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHA2 RECEPTOR TYROSINE KINASE; PROTEIN TYROSINE KINASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER RECURRENCE; CANCER SURVIVAL; DATA BASE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PREDICTION; PRIORITY JOURNAL;

BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECEPTOR, EPHA2; RECURRENCE; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037314612     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1999. CA - Cancer J. Clin., 49: 8-31, 1999.
2. Mountain, C. F. The evolution of the surgical treatment of lung cancer. Chest Surg. Clin. N. Am., 10: 83-104, 2000.
3. Mountain, C. F. The international system for staging lung cancer. Semin. Surg. Oncol., 18: 106-115, 2000.
4. D'Amico, T. A., Aloia, T. A., Moore, M. B., Conlon, D. H., Herndon, J. E., Kinch, M. S., and Harpole, D. H., Jr. Predicting the sites of metastases from lung cancer using molecular biologic markers. Ann. Thorac. Surg., 72: 1144-1148, 2001.
5. Lau, C. L., Harpole, D. H., Jr., and Patz, E. Staging techniques for lung cancer. Chest Surg. Clin. N. Am., 10: 781-801, 2000.
6. Lopez-Encuentra, A., Bulzebruck, H., Feinstein, A. R., Motta, G., Mountain, C. F., Naruke, T., Sanchez, J. M., Tsuchiya, R., and Wittekind, C. Tumor staging and classification in lung cancer. Summary of the international symposium. Madrid, Spain, 3-4 December 1999. Lung Cancer, 29: 79-83, 2000.
7. Sidransky, D. Emerging molecular markers of cancer. Nat. Rev. Cancer, 2: 210-219, 2002.
8. Magilligan, D. J., Jr., Duvernoy, C., Malik, G., Lewis, J. W., Jr., Knighton, R., and Ausman, J. I. Surgical approach to lung cancer with solitary cerebral metastasis: twenty-five years' experience. Ann. Thorac. Surg., 42: 360-364, 1986.
9. Figlin, R. A., Piantadosi. S., and Feld, R. Intracranial recurrence of carcinoma after complete surgical resection of stage I, II, and III non-small-cell lung cancer. N. Engl. J. Med., 318: 1300-1305, 1988.
10. Wiest, J. S., Franklin, W. A., Drabkin, H., Gemmill, R., Sidransky, D., and Anderson, M. W. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention. J. Cell. Biochem. Suppl., 28-29: 64-73, 1997.
11. Nesbitt, J. C., Putnam, J. B., Jr., Walsh, G. L., Roth, J. A., and Mountain, C. F. Survival in early stage non-small cell lung cancer. Ann. Thorac. Surg., 60: 466-472, 1995.
12. 0 non-small cell lung cancer. Lung Cancer Study Group. Ann. Thorac. Surg., 49: 242-246, 1990.
13. Zelinski, D. P., Zantek, N. D., Stewart, J. C., Irizarry, A. R., and Kinch, M. S. EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res., 61: 2301-2306, 2001.
14. Hess, A. R., Seftor, E. A., Gardner, L. M., Carles-Kinch, K., Schneider, G. B., Seftor, R. E., Kinch, M. S., and Hendrix, M. J. C. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). Cancer Res., 61: 3250-3255, 2001.
15. Carles-Kinch, K., Kilpatrick, K. E., Stewart, J. C., and Kinch, M. S. Antibody Targeting of the EphA2 receptor tyrosine kinase on malignant carcinomas. Cancer Res., 62: 2840-2847, 2001.
16. Walker-Daniels, J., Coffman, K., Azimi, M., Rhim, J. S., Bostwick, D. G., Snyder, P., Kerns, B. J., Waters, D. J., and Kinch, M. S. Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate, 41: 275-280, 1999.
17. Ogawa, K., Pasqualini, R., Lindberg, R. A., Kain, R., Freeman, A. L., and Pasquale, E. B. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene, 19: 6043-6052, 2000.
18. Rosenberg, I. M., Goke, M., Kanai, M., Reinecker, H. C., and Podolsky, D. K. Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function. Am. J. Physiol., 273: G824-G832, 1997.
19. Andres, A. C., Reid, H. H., Zurcher, G., Blaschke, R. J., Albrecht, D., and Ziemiecki, A. Expression of two novel eph-related receptor protein tyrosine kinases in mammary gland development and carcinogenesis. Oncogene, 9: 1461-1467, 1994.
20. Zantek, N. D., Walker-Daniels, J., Stewart, J. C., Hansen, R. K., Robinson, D., Miao, H., Wang, B., Kung, H. J., Bissell, M. J., and Kinch, M. S. MCF-10A-NeoST: a new cell system for studying cellECM and cell-cell interactions in breast cancer. Clin. Cancer Res., 7: 3640-3648, 2001.
21. Zantek, N. D., Zelinski, D. P., Peters, M. A., Taparowsky, E. J., and Kinch, M. S. Estrogen and myc negatively regulate expression of the EphA2 tyrosine kinase. J. Cell. Physiol., 85: 714-720, 2001.
22. Zantek, N. D., Azimi, M., Fedor-Chaiken, M., Wang, B., Brackenbury, R., and Kinch, M. S. Ecadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ., 10: 629-638, 1999.
23. Easty, D. J., and Bennett, D. C. Protein tyrosine kinases in malignant melanoma. Melanoma Res., 10: 401-411, 2000.
24. Easty, D. J., Herlyn, M., and Bennett, D. C. Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis. Int. J. Cancer, 60: 129-136, 1995.
25. Dohn, M., Jiang, J., and Chen, X. Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis. Oncogene, 20: 6503-6515, 2001.
26. Andres, A. C., Zuercher, G., Djonov, V., Flueck, M., and Ziemiecki, A. Protein tyrosine kinase expression during the estrous cycle and carcinogenesis of the mammary gland. Int. J. Cancer, 63: 288-296, 1995.
27. Dodelet, V. C., and Pasquale, E. B. Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene, 19: 5614-5619, 2000.
28. Gale, N. W., and Yancopoulos, G. D. Ephrins and their receptors: a repulsive topic? Cell Tissue Res., 290: 227-241, 1997.
29. Pandey, A., Lindberg, R. A., and Dixit, V. M. Cell signalling. Receptor orphans find a family. Curt. Biol., 5: 986-989, 1995.